BGB-3111-404
Not yet recruiting
A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström Macroglobulinemia
BeOne Study ID
ClinicalTrials.gov ID
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents
Locations
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents